Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CLVS

Clovis

$48.22

-1.71 (-3.42%)

, GILD

Gilead

$68.15

0.3 (0.44%)

04:55
05/24/18
05/24
04:55
05/24/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$48.22

-1.71 (-3.42%)

GILD

Gilead

$68.15

0.3 (0.44%)

PTLA

Portola Pharmaceuticals

$39.48

-0.71 (-1.77%)

DNLI

Denali Therapeutics

$20.33

0.32 (1.60%)

TBPH

Theravance Biopharma

$23.01

0.04 (0.17%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.70

0.1 (1.16%)

NKTR

Nektar

$82.81

0.87 (1.06%)

BMRN

BioMarin

$88.50

0.84 (0.96%)

RARE

Ultragenyx

$65.28

1.07 (1.67%)

EXEL

Exelixis

$20.59

-0.99 (-4.59%)

ANAB

AnaptysBio

$81.93

-4.25 (-4.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

Wednesday
EXEL

Exelixis

$20.46

-1.12 (-5.19%)

12:57
05/23/18
05/23
12:57
05/23/18
12:57
Recommendations
Exelixis analyst commentary at RBC Capital »

Exelixis pullback today a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

EXEL

Exelixis

$20.19

-1.39 (-6.44%)

12:41
05/23/18
05/23
12:41
05/23/18
12:41
Recommendations
Exelixis analyst commentary at RBC Capital »

Exelixis shares defended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

CLVS

Clovis

$49.93

0.24 (0.48%)

, GILD

Gilead

$67.85

0.22 (0.33%)

04:55
05/23/18
05/23
04:55
05/23/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$49.93

0.24 (0.48%)

GILD

Gilead

$67.85

0.22 (0.33%)

PTLA

Portola Pharmaceuticals

$40.19

-0.76 (-1.86%)

DNLI

Denali Therapeutics

$20.01

0.32 (1.63%)

TBPH

Theravance Biopharma

$22.97

-0.03 (-0.13%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.60

-0.1 (-1.15%)

NKTR

Nektar

$81.94

-1.46 (-1.75%)

BMRN

BioMarin

$87.66

-1.69 (-1.89%)

RARE

Ultragenyx

$64.21

-0.55 (-0.85%)

EXEL

Exelixis

$21.58

0.64 (3.06%)

ANAB

AnaptysBio

$86.18

-0.72 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

Tuesday
CLVS

Clovis

$49.69

-0.43 (-0.86%)

, GILD

Gilead

$67.63

-0.38 (-0.56%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$49.69

-0.43 (-0.86%)

GILD

Gilead

$67.63

-0.38 (-0.56%)

PTLA

Portola Pharmaceuticals

$40.95

-0.45 (-1.09%)

DNLI

Denali Therapeutics

$19.69

-0.02 (-0.10%)

TBPH

Theravance Biopharma

$23.00

-1.27 (-5.23%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$8.70

-0.425 (-4.66%)

NKTR

Nektar

$83.40

-1.9 (-2.23%)

BMRN

BioMarin

$89.35

0.4 (0.45%)

RARE

Ultragenyx

$64.76

-1.17 (-1.77%)

EXEL

Exelixis

$20.94

-0.64 (-2.97%)

ANAB

AnaptysBio

$86.90

-0.52 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

Monday
CLVS

Clovis

$50.12

-1.89 (-3.63%)

, GILD

Gilead

$68.01

0.41 (0.61%)

07:15
05/21/18
05/21
07:15
05/21/18
07:15
Conference/Events
Morgan Stanley to hold a tour »

2018 Biotech West Coast…

CLVS

Clovis

$50.12

-1.89 (-3.63%)

GILD

Gilead

$68.01

0.41 (0.61%)

PTLA

Portola Pharmaceuticals

$41.40

0.4 (0.98%)

DNLI

Denali Therapeutics

$19.71

0.72 (3.79%)

TBPH

Theravance Biopharma

$24.27

-0.19 (-0.78%)

DNA

Bought by RHHBY

$0.00

(0.00%)

CYTK

Cytokinetics

$9.13

0.025 (0.27%)

NKTR

Nektar

$85.30

6.075 (7.67%)

BMRN

BioMarin

$88.95

0.51 (0.58%)

RARE

Ultragenyx

$65.93

1.75 (2.73%)

EXEL

Exelixis

$21.58

0.02 (0.09%)

ANAB

AnaptysBio

$87.42

-1.92 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 25

    May

  • 02

    Jun

  • 12

    Jun

  • 12

    Sep

  • 13

    Nov

Over a week ago
EXEL

Exelixis

$20.40

-0.62 (-2.95%)

, IPSEY

Ipsen

$0.00

(0.00%)

05:29
05/17/18
05/17
05:29
05/17/18
05:29
Hot Stocks
Exelixis partner Ipsen announces EC approval of Cabometyx »

Exelixis (EXEL) announced…

EXEL

Exelixis

$20.40

-0.62 (-2.95%)

IPSEY

Ipsen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 12

    Jun

EXEL

Exelixis

$20.62

-0.1 (-0.48%)

13:15
05/15/18
05/15
13:15
05/15/18
13:15
Options
Exelixis put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 21

    May

  • 12

    Jun

EXEL

Exelixis

$19.55

-2.14 (-9.87%)

, RHHBY

Roche

$0.00

(0.00%)

11:00
05/10/18
05/10
11:00
05/10/18
11:00
Hot Stocks
Exelixis, Roche slide after colon cancer drug fails to meet primary study goal »

Shares of Exelixis (EXEL)…

EXEL

Exelixis

$19.55

-2.14 (-9.87%)

RHHBY

Roche

$0.00

(0.00%)

ARRY

Array BioPharma

$13.83

0.14 (1.02%)

BMY

Bristol-Myers

$51.49

0.41 (0.80%)

MRK

Merck

$58.29

0.33 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 15

    May

  • 21

    May

  • 21

    May

  • 30

    May

  • 05

    Jun

  • 12

    Jun

  • 30

    Jun

  • 30

    Jun

  • 10

    Jul

  • 23

    Oct

EXEL

Exelixis

$19.39

-2.3 (-10.60%)

10:14
05/10/18
05/10
10:14
05/10/18
10:14
Recommendations
Exelixis analyst commentary at Piper Jaffray »

Exelixis price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.